
Your Dog’s Gut After Antibiotics: What Really Happens and How to Rebuild It
Written by: Glendon Lloyd | Dip. Canine Nutrition (Dist.) | Dip. Canine Nutrigenomics (Dist.) | Founder, Bonza
Specialisms: Canine gut microbiome science, evidence-based nutrition, nutrigenomics, plant-based canine diets
Reviews 5–6 peer-reviewed studies weekly.
Why This Article Matters
Antibiotics save lives. When your dog has a serious bacterial infection, they are an essential tool in your vet’s arsenal. But every course of antibiotics comes with a hidden cost that most dog owners never hear about: significant, sometimes lasting, damage to the trillions of beneficial microorganisms living in your dog’s gut.
The canine gut microbiome is not simply a collection of bacteria that helps digest food. Research from Texas A&M University’s Gastrointestinal Laboratory, led by Professor Jan Suchodolski, one of the world’s foremost authorities on the canine microbiome, has established that this microbial community functions as what we at Bonza call a health command centre — regulating immune function, producing essential metabolites, converting bile acids, protecting against pathogens, and influencing organ systems from the brain to the skin through a network of gut-organ axes. 1,2
When antibiotics disrupt this command centre, the consequences can extend far beyond a bout of loose stools. Understanding what happens inside your dog’s gut during and after antibiotic therapy, and knowing how to support recovery through targeted nutrition, can make a meaningful difference to your dog’s short-term comfort and long-term health.
This article brings together the latest peer-reviewed research to explain what antibiotics do to the canine microbiome, which commonly prescribed antibiotics cause the most disruption, how long recovery takes, and what evidence-based nutritional strategies can help rebuild microbial health.
Key Takeaways
Any oral antibiotic course warrants gut support, regardless of whether it was prescribed for a gut condition, skin infection, UTI, or other issue.
Antibiotics damage the gut microbiome alongside the infection they treat. Research shows they reduce microbial diversity, deplete critical bacteria like C. hiranonis and Faecalibacterium, impair bile acid conversion, and promote pathogenic overgrowth.
Some antibiotics are harder on the gut than others. Metronidazole and tylosin (anaerobic-spectrum antibiotics) cause the most severe and prolonged dysbiosis. Amoxicillin-clavulanic acid has a more limited microbiome impact but promotes antibiotic-resistant bacteria.
Recovery is not guaranteed and varies widely between dogs. Microbiome effects persist for a minimum of four weeks after metronidazole and up to two months or more after tylosin. Some dogs may never fully return to their pre-antibiotic microbial profile.
Start nutritional gut support from day one — don’t wait until the course finishes. Heat-inactivated postbiotics (like HA-122) are unaffected by antibiotics and can be given alongside them immediately. Prebiotics and gut barrier nutrients such as L-glutamine also support recovery from the outset.
A multi-target approach is more effective than probiotics alone. The research supports combining prebiotics (chicory root inulin) to feed surviving beneficial bacteria, postbiotics (like L helveticus HA-122) to reduce pathogenic overgrowth, spore-forming probiotics (like Calsporin®) for microbial resilience, gut barrier nutrients (L-glutamine, zinc) for epithelial repair, and anti-inflammatory botanicals to manage dysbiosis-driven inflammation.
Gut disruption affects whole-body health, not just digestion. The gut microbiome communicates with the immune system, brain, skin, and metabolic pathways through gut-organ axes — meaning antibiotic-induced dysbiosis can manifest as immune suppression, skin changes, behavioural shifts, and metabolic disruption.
Continue gut support for at least four weeks after the last antibiotic dose — longer if your dog has had multiple courses or shows ongoing digestive changes.
Understanding Your Dog’s Gut Microbiome
Before we can understand what antibiotics damage, we need to appreciate what a healthy canine microbiome looks like and what it does.
A healthy adult dog’s gut harbours a remarkably diverse microbial community, with the five most abundant bacterial phyla being Firmicutes, Fusobacteria, Bacteroidetes, Proteobacteria, and Actinobacteria. 2,3 Within these broad groups, specific bacterial species perform critical functions that directly influence your dog’s health:
Clostridium (Peptacetobacter) hiranonis — The Bile Acid Converter
This bacterium is perhaps the single most important microbial marker in canine gut health. Peptacetobacter hiranonis (C. hiranonis) converts primary bile acids (produced by the liver) into secondary bile acids, a process essential for proper fat digestion, pathogen control, and metabolic signalling. Professor Suchodolski’s research has identified that a decreased abundance of C. hiranonis is one of the most consistent and clinically significant markers of dysbiosis in dogs. 1,4,5
Faecalibacterium prausnitzii — The Anti-Inflammatory Workhorse
A key producer of butyrate, the short-chain fatty acid (SCFA) that fuels the cells lining the colon, supports gut barrier integrity, and exerts potent anti-inflammatory effects. This bacterium is frequently depleted in dogs with chronic enteropathies and during antibiotic therapy. 2,6
Short-Chain Fatty Acid Producers
Bacteria from genera including Blautia, Fusobacterium, and Turicibacter produce SCFAs (butyrate, propionate, and acetate) that nourish colonocytes, regulate immune responses, maintain the intestinal mucus barrier, and help prevent colonisation by harmful bacteria. These are consistently among the taxa most affected by antibiotic treatment.1,2,5
The Dysbiosis Index
Suchodolski’s laboratory developed the Dysbiosis Index (DI), a validated PCR-based clinical tool that measures the abundance of seven key bacterial taxa in canine faecal samples and summarises the results as a single numerical score. A DI above 2 indicates significant dysbiosis; values between 0 and 2 indicate mild-to-moderate microbiome shifts. This tool has transformed how veterinary researchers and clinicians quantify gut health, and it features prominently in the antibiotic-disruption studies we’ll discuss below. 1,4
What Antibiotics Do to the Canine Gut Microbiome
The fundamental problem with antibiotics is that they cannot distinguish between the bacteria causing an infection and the beneficial bacteria in the gut. A comprehensive 2023 review by Stavroulaki, Suchodolski, and Xenoulis, published in The Veterinary Journal, synthesised the evidence across multiple antibiotic classes in dogs and cats. Their findings confirm that antimicrobial-induced dysbiosis involves decreases in microbial richness and diversity, loss of beneficial bacterial groups, blooms of intestinal pathogens, and alterations in metabolic functions and end-products of the microbiota. 7
Critically, antibiotics with an anaerobic spectrum of activity — which includes metronidazole and tylosin, two of the most commonly prescribed antibiotics for canine gastrointestinal conditions — tend to cause the most severe and prolonged dysbiosis, precisely because the vast majority (roughly 95%) of gut bacteria are anaerobic. 7,8
Metronidazole: The Most Studied — and Most Damaging
Metronidazole is one of the most widely prescribed antibiotics for canine gastrointestinal problems, particularly when Giardia or Clostridium perfringens infection is suspected. It is also one of the most extensively studied for its microbiome effects.
In a landmark 2020 study, Pilla et al. investigated the effects of 14 days of metronidazole in 24 healthy dogs. The results were striking: metronidazole significantly decreased microbial richness, with key bacteria such as Fusobacteria not fully recovering even four weeks after the antibiotic was discontinued. The Dysbiosis Index was significantly elevated during treatment. These microbiome changes were accompanied by increased faecal lactate (a marker of disturbed fermentation), increased markers of oxidative stress in both faeces and serum, and critically, impaired bile acid conversion — with seven of the 16 treated dogs still showing depressed secondary bile acid production and reduced C. hiranonis abundance four weeks after stopping the drug. Over half (56%) of the dogs developed diarrhoea during administration. 5
Key finding: The researchers concluded there was a “minimum 4-week effect of metronidazole on fecal microbiome and metabolome, supporting a cautious approach to prescription of metronidazole in dogs.” 5
A 2020 pilot study by Chaitman et al. comparing faecal microbiota transplantation (FMT) with metronidazole in dogs with acute diarrhoea reinforced these concerns. While both treatments improved faecal consistency within a week, at day 28 the metronidazole group still had significantly elevated Dysbiosis Index scores and altered microbial diversity compared to healthy controls — whereas the FMT group had returned to near-normal profiles. 9
Tylosin: Long-Lasting Individual Variation
Tylosin, a macrolide antibiotic commonly prescribed for dogs with chronic or tylosin-responsive diarrhoea, also causes significant microbiome disruption. Manchester et al. (2019) conducted a prospective randomised controlled trial in 16 healthy dogs, administering tylosin for just seven days. On day 7, treated dogs showed significantly decreased bacterial diversity, with particular losses in anaerobic families such as Fusobacteriaceae and Veillonellaceae. Primary bile acid concentrations remained elevated at both day 21 and day 63. 10
The most striking finding was the highly individualised nature of recovery. Two months after tylosin cessation, some dogs had generally recovered to their pre-treatment microbial profiles, while others showed markedly altered communities with proportional increases in potentially pathogenic Enterobacteriales. Of the five dogs with a normal DI at baseline and available day-63 samples, only two returned to a normal DI by that time. The researchers concluded that “two months after oral tylosin exposure, reestablishment of the native microbiota is possible but not guaranteed.” 10
Amoxicillin-Clavulanic Acid: Limited Microbiome Impact, but Resistance Concerns
Amoxicillin-clavulanic acid (marketed as Clavamox®/Synulox®) is one of the most frequently prescribed antibiotics in veterinary practice, including for gastrointestinal conditions. Werner et al. (2020) conducted a prospective, placebo-controlled, double-blinded study in 16 dogs with acute diarrhoea. The study found no significant difference in the Dysbiosis Index between the antibiotic and placebo groups, suggesting a more limited impact on the overall microbiome compared to metronidazole or tylosin. Professor Suchodolski’s later review confirmed that amoxicillin-clavulanic acid has a “limited effect on the DI and C. hiranonis.” 1,11
However, the Werner study did reveal a different cause for concern: the proportion of amoxicillin-resistant E. coli increased dramatically (to a median of 100%) during treatment and remained significantly elevated (median 10%) three weeks after the course ended. The study also noted that 38% of antibiotic-treated dogs tested positive for C. difficile at day 6 (compared to none at baseline), suggesting that even when the broader microbiome profile appears less disrupted, antibiotics may still promote colonisation by potentially pathogenic species. Importantly, no clinical benefit of the antibiotic was observed for acute diarrhoea. 11
The Broader Pattern Across Antibiotic Classes
While metronidazole and tylosin are the most studied, the pattern of antibiotic-induced dysbiosis is consistent across commonly prescribed canine antibiotics, including enrofloxacin (a fluoroquinolone) and doxycycline. The Stavroulaki et al. (2023) review identified that the spectrum of activity, duration of use, and dosage cannot always predict the extent and duration of dysbiosis for an individual dog. Microbial recovery can be “extremely individualised,” and repeated courses of the same antibiotic may affect the microbiome differently each time. 7
At a metabolic level, antibiotic disruption consistently targets the same critical pathways: reduced SCFA production (particularly butyrate), impaired bile acid conversion from primary to secondary forms, increased faecal lactate, and elevated oxidative stress markers. These aren’t abstract laboratory measurements — they translate directly into compromised gut barrier function, reduced immune regulation, and increased susceptibility to pathogenic colonisation. 2,5,7
How Long Does Recovery Take?
One of the most important questions dog owners ask is: “How long until my dog’s gut is back to normal?” The honest, evidence-based answer is: it depends, and in some cases, the microbiome may not fully return to its pre-antibiotic state.
Based on the published research, here is what we know about recovery timelines:
| Antibiotic | Typical Recovery | Key Evidence |
|---|---|---|
| Metronidazole | 4+ weeks; some dogs show persistent dysbiosis | 44% of dogs had persistent C. hiranonis depletion and bile acid dysmetabolism 4 weeks post-treatment (Pilla et al. 2020) |
| Tylosin | 2 weeks to 2+ months; highly individual | Most parameters returned to baseline by day 14, but some dogs still dysbiotic at 2 months. Recovery is “possible but not guaranteed” (Manchester et al. 2019) |
| Amoxicillin-clavulanic acid | 2–4 weeks for microbiome; 3+ weeks for resistance genes | Limited DI impact, but amoxicillin-resistant E. coli persisted 3 weeks post-treatment (Werner et al. 2020) |
| Broad-spectrum (general) | 2–4 weeks in most dogs; months in some | Suchodolski (2022): “normalises within 2–4 weeks after therapy in most animals, but some may have persistent dysbiosis for several months” |
The key insight from this body of research is that recovery is not uniform. Some dogs bounce back quickly; others may carry microbial imbalances for months. Factors that likely influence recovery include the individual dog’s baseline microbiome diversity, the specific antibiotic and duration of treatment, diet during and after the course, whether supportive measures (prebiotics, postbiotics) are provided, and the dog’s age and overall health status.
Beyond the Gut: Why Antibiotic-Induced Dysbiosis Matters for Whole-Body Health
The microbiome’s influence extends far beyond digestion. At Bonza, our messaging framework “One Gut. Whole Dog.” reflects the scientific reality that the gut microbiome communicates with virtually every organ system through what researchers call the gut-organ axes. When antibiotics disrupt the microbiome, the effects can ripple outward:
Gut-Immune Axis
An estimated 70–80% of immune cells reside in the gut-associated lymphoid tissue. Antibiotic-induced depletion of SCFA-producing bacteria reduces the signals that train and regulate immune responses, potentially increasing susceptibility to infections and inflammatory conditions. 2,3
Gut-Brain Axis
Gut bacteria produce neurotransmitter precursors including tryptophan metabolites. Disruption of microbial tryptophan metabolism has been associated with altered behaviour and neurological function in animal studies. 2
Gut-Skin Axis
Changes in microbial metabolite production can influence inflammatory pathways that manifest in the skin. Owners sometimes notice skin changes or increased itching during or after antibiotic courses — this may partly reflect the gut-skin connection.
Gut-Metabolic Axis
The impaired bile acid conversion seen during antibiotic treatment directly affects fat metabolism and metabolic signalling. The shift from secondary back to primary bile acids is one of the most consistent metabolic consequences of antibiotic-induced dysbiosis in dogs. 5,10
This interconnected web of gut-organ communication is precisely why supporting microbiome recovery after antibiotics isn’t just about resolving digestive symptoms — it’s about restoring the whole-body health network.
The Evidence for Nutritional Support During and After Antibiotics
The research points to five complementary nutritional strategies for supporting the microbiome during and after antibiotic therapy: prebiotics to feed surviving beneficial bacteria and promote their recovery, probiotics and postbiotics to provide direct microbial support and bioactive metabolites, gut barrier nutrients to repair the intestinal lining, anti-inflammatory botanicals to manage collateral inflammation, and dietary fibre to serve as fermentation substrate for SCFA production.
Prebiotics: Feeding the Survivors
Prebiotics are non-digestible compounds — principally fibres and oligosaccharides — that selectively promote the growth of beneficial gut bacteria. During and after antibiotic treatment, when beneficial populations are depleted, providing prebiotic substrate gives surviving good bacteria a competitive advantage as they attempt to recolonise. 2,12
A 2025 Frontiers in Veterinary Science study by Martini et al. investigated the fermentation characteristics of dietary fibres using faecal inocula from dogs treated with metronidazole. The research confirmed that antibiotic treatment significantly altered microbial fermentation capacity, but that dietary fibres could still serve as substrates for the remaining SCFA-producing bacteria — supporting the rationale for prebiotic inclusion during recovery. 12
Chicory root inulin, a well-studied prebiotic, is one of the key functional ingredients in Bonza’s Superfoods & Ancient Grains complete food and is present at significant levels in Bioactive Bites Belly and Biotics (3.63% of composition). As a fructo-oligosaccharide, inulin selectively promotes the growth of beneficial Bifidobacteria and Lactobacillus species, and supports SCFA production — the very metabolic pathways most damaged by antibiotics. [For a deep dive into the science of chicory root inulin, see our dedicated ingredient article.]
Postbiotics: Evidence from the HA-122 Research
One of the most directly relevant studies for post-antibiotic recovery comes from Deschamps et al. (2025), published in BMC Microbiology. This study tested Lactobacillus helveticus HA-122 as a heat-inactivated postbiotic in the CANIM-ARCOL model — a sophisticated artificial colon system that simulates the canine gut environment — specifically during and after simulated treatment with metronidazole and enrofloxacin (two commonly co-prescribed canine antibiotics). 13
The results demonstrated that HA-122 postbiotic supplementation during the antibiotic challenge reduced overgrowth of Enterobacteriaceae (a family of potentially pathogenic bacteria that typically blooms during antibiotic-induced dysbiosis) and accelerated recovery of the microbiome towards its pre-antibiotic composition after the antibiotics were withdrawn. This is precisely the kind of targeted, evidence-based support that matters during a period when the gut ecosystem is most vulnerable. 13
Supporting evidence comes from Duysburgh et al. (2025), who used the SHIME® canine gut simulator to demonstrate that a prebiotic-postbiotic blend restored microbial balance and SCFA production in a model of dogs with soft stools. 14 And Rawling et al. (2023) showed that HA-122 upregulated tight junction proteins essential for gut barrier integrity — the very barrier that antibiotics can compromise. 15
L. helveticus HA-122 is the active postbiotic in Bonza’s Biotics Bioactive Bites , our targeted gut health supplement. It is also included in Belly Bioactive Bites (digestion support) and Boost Bioactive Bites (vitality). As a heat-inactivated postbiotic, HA-122 is not a live organism — which means it is not affected by antibiotic co-administration and can be given alongside antibiotic therapy from day one. [Explore the full HA-122 evidence base in our dedicated ingredient article.]
Probiotics: Supporting the Living Ecosystem
While live probiotics face the obvious challenge of being potentially killed by concurrent antibiotics, evidence supports their use — particularly spore-forming probiotic strains that survive gastric and antibiotic challenges. Ziese et al. (2018) demonstrated in a placebo-controlled trial that probiotic treatment (Visbiome®) in dogs with acute haemorrhagic diarrhoea was associated with accelerated normalisation of the intestinal microbiome, with significantly higher abundance of beneficial Blautia and Faecalibacterium by day 7. 16
Bonza’s Superfoods & Ancient Grains novel protein dog food contains Calsporin® (Bacillus velezensis DSM 15544), a spore-forming probiotic specifically chosen for its resilience. Unlike fragile vegetative bacteria, Bacillus spores survive gastric acid, bile, and heat — and importantly, their spore form may offer a degree of protection against some antibiotic mechanisms. Calsporin® works by producing enzymes and metabolites that support the gut environment for other beneficial bacteria to recolonise. Calsporin® is also present in Belly Bioactive Bites , Biotics, and Boost — delivering 250,000,000 CFU/g in Belly and Biotics, and approximately 166,670,872 CFU/g in Boost — ensuring that dogs receiving any combination of Bonza products maintain consistent probiotic support even during antibiotic therapy. [Learn more about Calsporin® in our ingredient article.]
Yeast Cell Wall Fractions: MOS and Beta-Glucans
Superfoods & Ancient Grains includes yeast cell wall fractions providing mannan-oligosaccharides (MOS) and beta-glucans, and inactivated yeast is a significant component of Belly Bioactive Bites and Biotics (9.38% of composition).
MOS acts as a decoy binding site for pathogenic bacteria such as Salmonella and E. coli, reducing their ability to colonise the gut wall — particularly relevant when antibiotic disruption has removed the normal competitive barrier against pathogens. Swanson et al. (2002) demonstrated in dogs that supplemental MOS influenced immune function and microbial populations in the large bowel, including increased Lactobacillus counts and enhanced ileal IgA concentrations. 18
Beta-glucans, the other major bioactive fraction of yeast cell walls, provide direct immune support through the gut-immune axis. Middelbos et al. (2007) conducted a dose-response evaluation of yeast cell wall supplementation in adult dogs and demonstrated that higher inclusion levels enhanced immune indices, including increased serum IgA concentrations and altered white blood cell profiles consistent with improved immune readiness. 19 During antibiotic-induced dysbiosis, when the normal microbial signals that train immune function are diminished, this direct immunomodulatory effect of beta-glucans becomes particularly valuable — essentially providing an alternative immune stimulus while the microbiome is rebuilding.
Gut Barrier Repair: L-Glutamine and Zinc
Antibiotic-induced dysbiosis doesn’t just deplete beneficial bacteria — it also compromises the physical integrity of the intestinal barrier. Reduced SCFA production, particularly butyrate, means fewer resources for the colonocytes that form the gut lining, while inflammation and pathogenic overgrowth can further damage tight junctions between cells. Two nutrients play especially important roles in barrier repair and are included in Bonza’s Bioactive Bites formulations.
L-Glutamine is the primary metabolic fuel for enterocytes — the epithelial cells lining the intestinal tract. During periods of gut stress, including antibiotic-induced dysbiosis, enterocyte demand for glutamine increases substantially. L-Glutamine supports gut barrier integrity by fuelling enterocyte proliferation and repair, supporting mucin production that forms the protective mucus layer, and maintaining tight junction protein expression between cells. Pilla and Suchodolski (2020) noted in their comprehensive review that the metabolic consequences of dysbiosis include impaired gut barrier function and depleted SCFA production — the very conditions in which glutamine supplementation is most relevant. 2 L-Glutamine is included at 16,250 mg/kg in Belly Bioactive Bites and Biotics, providing targeted support for epithelial recovery during and after antibiotic courses.
Zinc is essential for epithelial cell integrity, wound healing, and immune function throughout the gastrointestinal tract. Zinc deficiency is associated with increased intestinal permeability and impaired mucosal repair, and supplementation has been shown to support tight junction integrity and reduce intestinal inflammation. Bonza uses zinc chelate of glycine hydrate — a highly bioavailable organic form — across all three Bioactive Bites formulations: 3,750 mg/kg in Belly and Biotics, and 2,638.9 mg/kg in Boost. Chelated zinc forms show superior absorption compared to inorganic zinc sources, ensuring effective delivery to the tissues that need it most during gut recovery. 20
Anti-Inflammatory and Adaptogenic Botanical Support
Antibiotic-induced dysbiosis triggers an inflammatory cascade in the gut. As beneficial bacteria are depleted, the loss of anti-inflammatory SCFAs (particularly butyrate) and the overgrowth of potentially pathogenic species create a pro-inflammatory environment. Bonza’s formulations include a targeted selection of anti-inflammatory and adaptogenic botanicals — collectively forming the PhytoPlus® blend — to address this inflammation directly while the microbiome rebuilds.
Boswellia serrata (Indian frankincense) is included across all three Bioactive Bites supplements. The boswellic acids in Boswellia inhibit 5-lipoxygenase, a key inflammatory enzyme, providing anti-inflammatory support without the gastric side effects associated with conventional non-steroidal anti-inflammatory drugs. Reichling et al. (2004) demonstrated that dietary Boswellia resin produced clinically relevant improvements in dogs with inflammatory joint and spinal disease, confirming the bioavailability and efficacy of orally administered boswellic acids in the canine species. 21 In the context of antibiotic recovery, this anti-inflammatory activity helps manage the gut inflammation driven by dysbiosis-related pathogenic overgrowth.
Turmeric (Curcuma longa), present in Belly, Biotics, and Boost, provides curcumin — a polyphenol with extensively documented anti-inflammatory and antioxidant properties. Curcumin modulates NF-κB and other inflammatory signalling pathways relevant to gut inflammation. Importantly, Bioactive Bites Belly and Biotics also include black pepper (Piper nigrum) at 500 mg/kg, which contains piperine — shown to enhance curcumin bioavailability by up to 2,000% through inhibition of glucuronidation in the gut and liver. 22 [See our dedicated turmeric ingredient article for the full evidence base.]
Ginger (Zingiber officinale), included in all three supplements, has a long history in veterinary herbal medicine for digestive support. Ginger’s gingerol and shogaol compounds provide anti-inflammatory effects through COX-2 and 5-LOX inhibition, while also supporting gastric motility and reducing nausea — common concerns during antibiotic therapy. Platel and Srinivasan (2004) demonstrated that ginger stimulates digestive enzyme activity and bile secretion, supporting the digestive processes that are compromised when antibiotic-induced dysbiosis impairs normal bile acid conversion. 23
Chamomile (Matricaria recutita), present across all three Bioactive Bites formulations, provides apigenin and bisabolol — compounds with anti-inflammatory, antispasmodic, and gut-soothing properties. Chamomile’s traditional use for gastrointestinal discomfort is supported by its demonstrated ability to reduce smooth muscle spasm and calm mucosal inflammation, making it particularly relevant for the digestive discomfort that frequently accompanies antibiotic courses.
These botanicals work synergistically with the microbial support provided by HA-122 postbiotic and Calsporin® probiotic. While the prebiotics and probiotics focus on rebuilding the microbial ecosystem, the PhytoPlus® botanical blend manages the inflammatory environment — creating conditions that favour microbial recolonisation rather than continued pathogenic overgrowth.
Additional Functional Ingredients Supporting Recovery
Several other ingredients in Bonza’s Bioactive Bites formulations contribute to the broader recovery picture:
Spirulina (0.75% in Belly and Biotics) is a nutrient-dense cyanobacterium rich in phycocyanin, a potent antioxidant. Given that Pilla et al. (2020) documented increased markers of oxidative stress during metronidazole treatment, antioxidant support is a relevant consideration during antibiotic recovery. 5
Pumpkin seed flour (1% across all three supplements) provides additional soluble and insoluble fibre that supports microbial fermentation, consistent with the Martini et al. (2025) finding that dietary fibres serve as substrates for remaining SCFA-producing bacteria even during antibiotic disruption. 12
Cranberry (1% across all three supplements) provides proanthocyanidins with anti-adhesion properties against uropathogenic bacteria, offering complementary pathogen-management support alongside MOS.
DHA-rich algae (Schizochytrium sp., 1% across all three supplements) provides omega-3 fatty acids with anti-inflammatory properties, supporting the resolution of gut inflammation through a different mechanistic pathway to the botanical anti-inflammatories. [See our dedicated DHA-algae ingredient article.]
A Note on Antibiotic Stewardship
This article is not anti-antibiotic. Antibiotics are essential, life-saving medications when appropriately prescribed. The veterinary evidence increasingly supports judicious use — reserving antibiotics for cases where they are genuinely needed rather than prescribing them empirically for conditions that may resolve without them.
The Werner et al. (2020) study on amoxicillin-clavulanic acid found no clinical benefit for uncomplicated acute diarrhoea, leading the authors to support international guidelines recommending that dogs with diarrhoea should not receive antibiotics unless there are signs of sepsis. 11 Similarly, the Pilla and Suchodolski (2020) review notes that studies have found no difference in clinical recovery between dogs receiving metronidazole and prednisone versus prednisone alone for chronic enteropathies, and no difference in mortality or outcomes when antibiotics were compared with placebo in non-septic dogs with acute haemorrhagic diarrhoea. 2
These findings reinforce the message: when your vet prescribes antibiotics, trust their clinical judgement — but also understand that supporting your dog’s gut through, and after, the course is a proactive step you can take as an owner.
How to Support Your Dog’s Gut During and After Antibiotics
Based on the evidence reviewed above, here is a practical, step-by-step framework for supporting your dog’s microbiome through an antibiotic course and into recovery.
- Start nutritional support from day one of the antibiotic course.
Don’t wait until the course is finished. The Deschamps et al. (2025) study tested HA-122 postbiotic during simulated antibiotic treatment, not just afterwards, and showed benefits in reducing pathogenic overgrowth during the challenge period itself. 13 A postbiotic like HA-122, being heat-inactivated, is unaffected by concurrent antibiotics — making it immediately deployable. Prebiotics like inulin and gut barrier nutrients such as L-glutamine can also begin supporting surviving beneficial bacteria and intestinal repair from day one.
- Feed a microbiome-supportive diet throughout.
A complete food providing prebiotic fibre (such as chicory root inulin), spore-forming probiotics (such as Calsporin®), and pathogen-binding compounds (such as yeast cell wall MOS and beta-glucans) provides a continuous nutritional foundation for microbial resilience. Bonza’s Superfoods & Ancient Grains is formulated to deliver exactly this combination.
- Add targeted gut support supplements.
Bonza’s Biotics Bioactive Bites provides L. helveticus HA-122 postbiotic, Calsporin® probiotic, chicory root prebiotic, yeast cell wall MOS and beta-glucans, L-glutamine for gut barrier repair, zinc for epithelial integrity, and the PhytoPlus® anti-inflammatory botanical blend — all at levels supported by the research evidence. For dogs on antibiotics, this is the primary recommended supplement. If your dog also has digestive discomfort, Belly Bioactive Bites provides the same gut-support formulation with additional digestive-support compounds. If they appear lethargic or low in energy during the course, Bioactive Bites Boost provides vitality support with HA-122 and Calsporin®.
- If using live probiotics, time them strategically.
If you are also giving a live probiotic, administer it as far apart from the antibiotic dose as possible (ideally at opposite ends of the day). This maximises the window in which live organisms can exert their effects before the next antibiotic dose. Spore-forming probiotics like Bacillus velezensis (Calsporin®) have inherently greater antibiotic resilience than vegetative forms.
- Continue support for at least four weeks after the antibiotic course ends.
The research consistently shows that the microbiome effects of antibiotics persist well beyond the last dose. Pilla et al. (2020) documented effects lasting at least four weeks after metronidazole; Manchester et al. (2019) found effects persisting up to two months after tylosin. 5,10 Continue prebiotic, postbiotic, gut barrier, and dietary support throughout this recovery window. Many dogs may benefit from continuing supplementation beyond this period, particularly if they have had multiple antibiotic courses.
- Monitor your dog’s stools and overall condition.
Faecal consistency is one of the most accessible indicators of gut health. During and after antibiotics, note changes in stool firmness, colour, frequency, and any mucus or straining. Persistent loose stools beyond the antibiotic course warrant a conversation with your vet. Also watch for secondary signs of gut disruption such as excessive flatulence, reduced appetite, lethargy, or skin changes.
- Discuss the Dysbiosis Index with your vet for dogs with ongoing issues.
If your dog experiences persistent digestive problems after antibiotics, ask your vet about the Dysbiosis Index test. This validated tool, available through veterinary laboratories, can quantify the extent of microbiome disruption and provide a baseline for monitoring recovery. 1,4
- Avoid unnecessary repeat courses.
If your dog’s condition does not clearly require antibiotics, discuss alternatives with your vet. The evidence increasingly supports dietary management, probiotics, and other non-antibiotic approaches as first-line treatments for many gastrointestinal conditions in dogs. 2,11
The Bonza Approach: A Food-Plus-Supplement System
At Bonza, we’ve designed our products as a complementary system, not a single-product solution. For dogs going through or recovering from antibiotics, the evidence-based approach combines:
The Foundation: Superfoods & Ancient Grains Complete Food
Provides daily prebiotic support through chicory root inulin, spore-forming probiotic Bacillus velezensis (Calsporin®), yeast cell wall fractions (MOS and beta-glucans) for pathogen binding and immune support, and the PhytoPlus® adaptogen blend for whole-body resilience.
Targeted Support: Bioactive Bites Biotics (Primary Recommendation)
Delivers L. helveticus HA-122 heat-inactivated postbiotic, supported by the Deschamps et al. (2025) evidence for reducing pathogenic overgrowth during antibiotic challenge and accelerating post-antibiotic microbiome recovery. 13 Also provides Calsporin® (B. velezensis) at 250,000,000 CFU/g, chicory root inulin (3.63%), inactivated yeast for MOS and beta-glucans (9.38%), L-glutamine (16,250 mg/kg) for gut barrier repair, zinc chelate (3,750 mg/kg) for epithelial integrity, and the PhytoPlus® anti-inflammatory botanical blend including Boswellia, turmeric with black pepper for enhanced bioavailability, ginger, and chamomile. Can be started from day one of the antibiotic course and continued for at least four weeks after.
Additional Support If Needed
Belly Bioactive Bites — if digestive discomfort (soft stools, flatulence, reduced appetite) is prominent during or after the antibiotic course. Contains the same core gut-support formulation as Biotics (HA-122, Calsporin®, chicory root inulin, yeast cell wall, L-glutamine, zinc, PhytoPlus® botanicals) with additional digestive-support compounds including pineapple (Ananas comosus), which provides natural bromelain enzymes to support protein digestion during periods of compromised gut function.
Boost Bioactive Bites — if lethargy, reduced vitality, or general “offness” accompanies the antibiotic course. Contains HA-122 and Calsporin® alongside vitality-supporting ingredients including glucosamine, chondroitin, MSM, hyaluronic acid, L-carnitine, DHA-rich algae, hemp seed oil, and the PhytoPlus® adaptogen blend (including ashwagandha, Siberian ginseng, and echinacea alongside turmeric, ginger, boswellia, and chamomile). Boost’s broader PhytoPlus® formulation includes adaptogenic herbs that support the body’s stress response during the physiological demands of antibiotic recovery, while milk thistle (Silybum marianum) provides hepatoprotective support — relevant given that many antibiotics are hepatically metabolised.
Frequently Asked Questions
Yes. Heat-inactivated postbiotics like HA-122 (found in Biotics Bioactive Bites , Belly, and Boost) are unaffected by antibiotics and can be given at any time during the course. Spore-forming probiotics like Calsporin® also have strong survivability. For live probiotic supplements, give them at least two hours apart from each antibiotic dose.
The most common side effects are gastrointestinal: diarrhoea, soft stools, vomiting, loss of appetite, and flatulence — 56% of healthy dogs developed diarrhoea during metronidazole in the Pilla et al. (2020) study. 5 Less visible effects include impaired bile acid conversion, increased oxidative stress, and reduced immune regulation through the gut-immune axis. Some dogs also experience lethargy, skin changes, or yeast overgrowth. Contact your vet immediately if you see bloody diarrhoea, persistent vomiting, or signs of allergic reaction.
Visible stool changes typically improve within a few days to two weeks after the final dose. However, the underlying microbial disruption lasts far longer — at least four weeks after metronidazole and up to two months after tylosin. 5,10 Stool normalisation does not mean the microbiome has recovered. If diarrhoea persists beyond a week after completing the course, or contains blood or mucus, consult your vet.
Maintain a consistent, high-quality diet — sudden changes add stress to an already disrupted gut. A microbiome-supportive food providing prebiotic fibre, spore-forming probiotics, and pathogen-binding compounds (like Bonza’s Superfoods & Ancient Grains) gives the gut its best foundation during treatment. Avoid highly processed treats or foods high in simple sugars, as these can feed opportunistic bacteria and yeast that thrive during dysbiosis.
Loss of appetite is a common antibiotic side effect. Try warming food slightly to enhance aroma, offering smaller meals more frequently, and ensuring fresh water is always available. Bioactive Bites can be offered as a palatable supplement even when appetite for main meals is reduced. If your dog refuses all food for more than 24 hours, or appetite loss is accompanied by vomiting or lethargy, contact your vet.
Effective restoration requires a multi-target approach: prebiotics (chicory root inulin) to feed surviving beneficial bacteria, postbiotics (HA-122) to reduce pathogenic overgrowth, spore-forming probiotics (Calsporin®) for antibiotic-resilient microbial support, gut barrier nutrients (L-glutamine, zinc) for intestinal repair, and anti-inflammatory botanicals to manage dysbiosis-driven inflammation. Start during the antibiotic course — not after — and continue for at least four weeks post-treatment. 13 Bonza’s Superfoods & Ancient Grains combined with Bioactive Bites Biotics provides all five layers.
Yes. Manchester et al. (2019) found that two months after just seven days of tylosin, some dogs had not returned to their pre-treatment microbial profiles. Only two out of five dogs with normal baseline Dysbiosis Index scores recovered by day 63 — the researchers concluded recovery is “possible but not guaranteed.” 10 The Stavroulaki et al. (2023) review confirmed that recovery is “extremely individualised” and repeated courses may affect the microbiome differently each time. 7
Watch for persistent soft stools or diarrhoea beyond the treatment period, excessive or foul-smelling flatulence, mucus in stools, reduced appetite, lethargy, skin changes or increased itching (reflecting the gut-skin axis), recurrent ear infections or yeast overgrowth, and a general “not quite right” demeanour. If symptoms persist beyond two to three weeks post-antibiotics, discuss the Dysbiosis Index test with your vet. 4
Yes. Metronidazole and tylosin (anaerobic-spectrum antibiotics) cause the most severe and prolonged dysbiosis because roughly 95% of gut bacteria are anaerobes. 7,8 Metronidazole consistently shows the greatest impact, with effects persisting at least four weeks. 5 Amoxicillin-clavulanic acid has a more limited microbiome impact but promotes antibiotic-resistant E. coli that can persist for weeks. 11 Understanding these differences helps calibrate your gut support strategy.
Avoid sudden dietary changes during an antibiotic course — the gut is already under stress. If you’re considering transitioning to a more supportive food, make the change before or well after the course rather than during it. Adding targeted supplements like Biotics Bioactive Bites during treatment is supported by the evidence, as it provides gut-supportive nutrients without changing the base diet.
Yes. Oral antibiotics affect the gut microbiome regardless of the infection site. The studies in this article used systemic antibiotics, and microbiome disruption occurred even in dogs with no gastrointestinal issues. Any oral antibiotic course warrants gut support from day one.
At least four weeks after the final dose. Microbiome disruption persists for a minimum of four weeks after metronidazole and potentially two months or more after tylosin. 5,10 If your dog has had multiple antibiotic courses or shows ongoing digestive changes, longer-term support is advisable. For dogs with a history of repeated antibiotic use, ongoing daily support through a microbiome-supportive food like Bonza’s Superfoods & Ancient Grains is a practical long-term strategy.
This is a legitimate concern. Werner et al. (2020) showed amoxicillin-resistant E. coli reached 100% prevalence during treatment and remained elevated three weeks later, while 38% of treated dogs tested positive for C. difficile by day 6. 11 Complete the full prescribed course, support the microbiome to reduce the need for repeat courses, and discuss with your vet whether antibiotics are truly necessary — the evidence shows no clinical benefit for uncomplicated acute diarrhoea. 2,11
For uncomplicated acute diarrhoea without signs of sepsis, the evidence increasingly supports non-antibiotic first-line management. Werner et al. (2020) found no clinical benefit from amoxicillin-clavulanic acid for acute diarrhoea. 11 Dietary management, prebiotics, probiotics, and postbiotics are evidence-based options that support rather than disrupt the microbiome. However, antibiotics remain essential when there are signs of systemic infection or sepsis — never withhold prescribed antibiotics without consulting your vet.
The research suggests each course impacts the microbiome, and recovery from repeated exposure may be more challenging. Dogs with a history of multiple courses may have reduced baseline diversity, making each subsequent disruption harder to recover from. 7 For these dogs, ongoing daily microbiome support is particularly important — Bonza’s Superfoods & Ancient Grains provides continuous foundational support, while Bioactive Bites Biotics delivers additional postbiotic, gut barrier, and anti-inflammatory support during and after each course.
Conclusion
The science is clear: antibiotics save lives, but they also inflict significant collateral damage on the canine gut microbiome. Research from the world’s leading veterinary microbiome laboratories has documented that commonly prescribed canine antibiotics reduce microbial diversity, deplete key beneficial bacteria such as C. hiranonis and Faecalibacterium, impair bile acid conversion and SCFA production, promote pathogenic overgrowth, and that recovery is highly individual and can take weeks to months.
The good news is that the same body of research points to clear, evidence-based strategies for supporting the gut through this challenge. Prebiotics, postbiotics, spore-forming probiotics, gut barrier nutrients, and anti-inflammatory botanicals can be deployed from day one of an antibiotic course. The Deschamps et al. (2025) study on HA-122 postbiotic provides the strongest direct evidence for a nutritional intervention that actively reduces pathogenic overgrowth during antibiotic challenge and accelerates recovery afterward. 13
Bonza’s Bioactive Bites – Biotics, Belly and Boost are each formulated to deliver multiple layers of gut support — from microbial rebuilding through HA-122 postbiotic and Calsporin® probiotic, to barrier repair through L-glutamine and zinc, to inflammation management through the PhytoPlus® botanical blend — reflecting the multi-target reality of antibiotic recovery. Combined with the daily foundation of Superfoods & Ancient Grains, this system provides comprehensive, evidence-based nutritional support for every stage of the antibiotic journey.
At Bonza, we believe that “One Gut. Whole Dog.” isn’t just a tagline — it’s a scientific principle. The gut microbiome is the health command centre, and when antibiotics are necessary, giving your dog’s gut the nutritional tools to defend, recover, and rebuild is one of the most impactful things you can do as a responsible owner.
Add years to their life, and life to their years.
Editorial Information
| Last reviewed | February 2026 |
| Next review due | February 2027 |
| Author | Glendon Lloyd | Dip. Canine Nutrition (Dist.) | Dip. Canine Nutrigenomics (Dist.) | Founder, Bonza |
| Medical disclaimer | This article is for educational purposes only and does not constitute veterinary medical advice. Always consult your veterinarian before making changes to your dog’s treatment plan, including adding supplements during an antibiotic course. |
References
- Suchodolski JS. Analysis of the gut microbiome in dogs and cats. Vet Clin Pathol. 2022;50(Suppl 1):6–17. doi:10.1111/vcp.13031
- Pilla R, Suchodolski JS. The Role of the Canine Gut Microbiome and Metabolome in Health and Gastrointestinal Disease. Front Vet Sci. 2020 Jan 14;6:498. doi: 10.3389/fvets.2019.00498. PMID: 31993446; PMCID: PMC6971114.
- Suchodolski JS. Intestinal microbiota of dogs and cats: a bigger world than we thought. Vet Clin North Am Small Anim Pract. 2011 Mar;41(2):261-72. doi: 10.1016/j.cvsm.2010.12.006. PMID: 21486635; PMCID: PMC7132526.
- AlShawaqfeh MK, Wajid B, Minamoto Y, Markel M, Lidbury JA, Steiner JM, Serpedin E, Suchodolski JS. A dysbiosis index to assess microbial changes in fecal samples of dogs with chronic inflammatory enteropathy. FEMS Microbiol Ecol. 2017 Nov 1;93(11). doi: 10.1093/femsec/fix136. PMID: 29040443.
- Pilla R, Gaschen FP, Barr JW, Olson E, Honneffer J, Guard BC, Blake AB, Villanueva D, Khattab MR, AlShawaqfeh MK, Lidbury JA, Steiner JM, Suchodolski JS. Effects of metronidazole on the fecal microbiome and metabolome in healthy dogs. J Vet Intern Med. 2020 Sep;34(5):1853-1866. doi: 10.1111/jvim.15871. Epub 2020 Aug 28. PMID: 32856349; PMCID: PMC7517498.
- Ziese AL, Suchodolski JS. Impact of Changes in Gastrointestinal Microbiota in Canine and Feline Digestive Diseases. Vet Clin North Am Small Anim Pract. 2021 Jan;51(1):155-169. doi: 10.1016/j.cvsm.2020.09.004. Epub 2020 Oct 29. PMID: 33131916.
- Stavroulaki EM, Suchodolski JS, Xenoulis PG. Effects of antimicrobials on the gastrointestinal microbiota of dogs and cats. Vet J. 2023 Jan;291:105929. doi: 10.1016/j.tvjl.2022.105929. Epub 2022 Nov 24. PMID: 36427604.
- Suchodolski JS, Dowd SE, Westermarck E, Steiner JM, Wolcott RD, Spillmann T, Harmoinen JA. The effect of the macrolide antibiotic tylosin on microbial diversity in the canine small intestine as demonstrated by massive parallel 16S rRNA gene sequencing. BMC Microbiol. 2009 Oct 2;9:210. doi: 10.1186/1471-2180-9-210. PMID: 19799792; PMCID: PMC2759960.
- Chaitman J, Ziese AL, Pilla R, Minamoto Y, Blake AB, Guard BC, Isaiah A, Lidbury JA, Steiner JM, Unterer S, Suchodolski JS. Fecal Microbial and Metabolic Profiles in Dogs With Acute Diarrhea Receiving Either Fecal Microbiota Transplantation or Oral Metronidazole. Front Vet Sci. 2020 Apr 16;7:192. doi: 10.3389/fvets.2020.00192. PMID: 32363202; PMCID: PMC7182012.
- Manchester AC, Webb CB, Blake AB, Sarwar F, Lidbury JA, Steiner JM, Suchodolski JS. Long-term impact of tylosin on fecal microbiota and fecal bile acids of healthy dogs. J Vet Intern Med. 2019 Nov;33(6):2605-2617. doi: 10.1111/jvim.15635. Epub 2019 Oct 31. PMID: 31674054; PMCID: PMC6872867.
- Werner M, Suchodolski JS, Straubinger RK, Wolf G, Steiner JM, Lidbury JA, Neuerer F, Hartmann K, Unterer S. Effect of amoxicillin-clavulanic acid on clinical scores, intestinal microbiome, and amoxicillin-resistant Escherichia coli in dogs with uncomplicated acute diarrhea. J Vet Intern Med. 2020 May;34(3):1166-1176. doi: 10.1111/jvim.15775. Epub 2020 Apr 23. PMID: 32324947; PMCID: PMC7255678.
- Martini SE, Oba PM, Geary EL, Bauer LL, Dilger RN, Swanson KS. In vitro fermentation characteristics of dietary fibers using fecal inocula from dogs fed a canned diet and treated with metronidazole. Front Vet Sci. 2025;12:1670624. Published 2025 Oct 29. doi:10.3389/fvets.2025.1670624
- Deschamps C, Humbert D, Brun M, Denis S, Durif C, Apper E, Blanquet-Diot S. Lactobacillus helveticus-derived postbiotic and live Saccharomyces boulardii restore gut microbiota after antibiotic disturbance in an in vitro canine gut model. Benef Microbes. 2025 Jul 24:1-21. doi: 10.1163/18762891-bja00088. Epub ahead of print. PMID: 40716759.
- Gramenzi A, Clerico L, Belà B, Di Leonardo M, Fusaro I, Pignataro G. Metabolic profiling of prebiotic, probiotic, and synbiotic supplements in a canine colonic fermentation model: a pilot feasibility study reveals distinct and complementary effects. Front Vet Sci. 2025;12:1641809. Published 2025 Nov 17. doi:10.3389/fvets.2025.1641809
- Rawling M, Schiavone M, Mugnier A, et al. Modulation of Zebrafish (Danio rerio) Intestinal Mucosal Barrier Function Fed Different Postbiotics and a Probiotic from Lactobacilli. Microorganisms. 2023;11(12):2900. Published 2023 Nov 30. doi:10.3390/microorganisms11122900
- Ziese AL, Suchodolski JS, Hartmann K, Busch K, Anderson A, Sarwar F, Sindern N, Unterer S. Effect of probiotic treatment on the clinical course, intestinal microbiome, and toxigenic Clostridium perfringens in dogs with acute hemorrhagic diarrhea. PLoS One. 2018 Sep 27;13(9):e0204691. doi: 10.1371/journal.pone.0204691. Erratum in: PLoS One. 2023 Jan 12;18(1):e0280539. doi: 10.1371/journal.pone.0280539. PMID: 30261077; PMCID: PMC6160196.
- Taverniti V, Guglielmetti S. Health-Promoting Properties of Lactobacillus helveticus. Front Microbiol. 2012 Nov 19;3:392. doi: 10.3389/fmicb.2012.00392. PMID: 23181058; PMCID: PMC3500876.
- Swanson KS, Grieshop CM, Flickinger EA, et al. Supplemental fructooligosaccharides and mannanoligosaccharides influence immune function, ileal and total tract nutrient digestibilities, microbial populations and concentrations of protein catabolites in the large bowel of dogs. J Nutr. 2002;132(5):980–989. doi:10.1093/jn/132.5.980
- Middelbos IS, Godoy MR, Fastinger ND, Fahey GC Jr. A dose-response evaluation of spray-dried yeast cell wall supplementation of diets fed to adult dogs: effects on nutrient digestibility, immune indices, and fecal microbial populations. J Anim Sci. 2007 Nov;85(11):3022-32. doi: 10.2527/jas.2007-0079. Epub 2007 Jul 20. PMID: 17644789.
- Wedekind KJ, Hortin AE, Baker DH. Methodology for assessing zinc bioavailability: efficacy estimates for zinc-methionine, zinc sulfate, and zinc oxide. J Anim Sci. 1992 Jan;70(1):178-87. doi: 10.2527/1992.701178x. PMID: 1582905.
- Reichling J, Schmökel H, Fitzi J, Bucher S, Saller R. Dietary support with Boswellia resin in canine inflammatory joint and spinal disease. Schweiz Arch Tierheilkd. 2004 Feb;146(2):71-9. doi: 10.1024/0036-7281.146.2.71. PMID: 14994484.
- Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PSSR. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64(4):353–356. doi:10.1055/s-2006-957450
- Platel K, Srinivasan K. Digestive stimulant action of spices: a myth or reality? Indian J Med Res. 2004 May;119(5):167-79. PMID: 15218978.